A system to estimate relapse-free survival probabilities and probable benefit from adjuvant therapy in patients with operable breast cancer.

被引：0
|
作者：
Miles, DW
Ryder, K
Rubens, RD
Royston, P
机构：
[1] Guys Hosp, London SE1 9RT, England
[2] MRC, Clin Trials Unit, London, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
240
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [41] Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin
    Watanabe, Ken
    Igarashi, Takao
    Uchiyama, Mayuki
    Ojiri, Hiroya
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (12) : 920 - 925
  • [42] Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin
    Ken Watanabe
    Takao Igarashi
    Mayuki Uchiyama
    Hiroya Ojiri
    Annals of Nuclear Medicine, 2020, 34 : 920 - 925
  • [43] GETTING FREE OF BREAST-CANCER - AN 8-YEAR PERSPECTIVE OF THE RELAPSE-FREE PATIENTS
    HALTTUNEN, A
    HIETANEN, P
    JALLINOJA, P
    LONNQVIST, J
    ACTA ONCOLOGICA, 1992, 31 (03) : 307 - 310
  • [44] DEVELOPMENT AND VALIDATION OF A NOVEL EPIGENETIC REGULATION RELATED SIGNATURE PREDICTING RELAPSE-FREE SURVIVAL IN COLON CANCER.
    Li, X.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E214 - E214
  • [45] Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer
    Ricciardelli, C
    Brooks, JH
    Suwiwat, S
    Sakko, AJ
    Mayne, K
    Raymond, WA
    Seshadri, R
    LeBaron, RG
    Horsfall, DJ
    CLINICAL CANCER RESEARCH, 2002, 8 (04) : 1054 - 1060
  • [46] Protein profiles (proteamics) discriminating between relapses versus relapse-free survival after adjuvant tamoxifen in 272 patients with primary estrogen receptor (ER) and progesterone receptor (PgR) positive breast cancer.
    Linderholm, BK
    Lehtio, J
    Ploner, A
    Pawitan, Y
    Skoog, L
    Lewensohn, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 863S - 863S
  • [47] Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF
    Sanchez, B. C.
    Sundqvist, M.
    Fohlin, H.
    Spyratos, F.
    Nordenskjold, B.
    Stal, O.
    Linderholm, B. K.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (09) : 1580 - 1587
  • [48] Effect of xenon anaesthesia on relapse-free survival in treatment of breast cancer: relation with immune status
    Avdeev, S.
    Stakheeva, M.
    Odyshev, V
    Faltin, V
    Slonimskay, E.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 : 11 - 11
  • [49] COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS
    Hofmann, Guenter
    Langsenlehner, Tanja
    Moazedi-Fuerst, Florentine
    Gerger, Armin
    Kielhauser, Sonja
    Absenger, Gudrun
    Szkandera, Joanna
    Samonigg, Hellmut
    Krippl, Peter
    Renner, Wilfried
    ANNALS OF ONCOLOGY, 2012, 23 : 86 - 87
  • [50] Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy
    Li, JunJie
    Chen, Sheng
    Chen, CanMing
    Di, GenHong
    Liu, GuangYu
    Wu, Jiong
    Shao, ZhiMin
    ONCOTARGET, 2017, 8 (11) : 18399 - 18408
12345